Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
1(5%)
Results Posted
33%(5 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
2
9%
Ph phase_1
3
14%
Ph not_applicable
12
55%
Ph phase_3
3
14%
Ph phase_2
2
9%

Phase Distribution

3

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
2(9.1%)
Phase 3Large-scale testing
3(13.6%)
Phase 4Post-market surveillance
2(9.1%)
N/ANon-phased studies
12(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(1)
Completed(15)
Terminated(2)
Other(4)

Detailed Status

Completed15
unknown4
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
93.8%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (13.6%)
Phase 22 (9.1%)
Phase 33 (13.6%)
Phase 42 (9.1%)
N/A12 (54.5%)

Trials by Status

unknown418%
withdrawn15%
completed1568%
recruiting15%
terminated15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT03933631Phase 3

Pilocarpine Use After Kahook Goniotomy

Recruiting
NCT04675151Phase 2

Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

Completed
NCT06752278Not Applicable

Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye

Completed
NCT05506137Phase 3

Xerostomia in Patients With a Life-limiting Condition or Frailty

Unknown
NCT04005079Phase 3

Pilocarpine After Combined Cataract/Trabectome Surgery

Withdrawn
NCT02865473Not Applicable

Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study

Unknown
NCT03460964Not Applicable

Measuring Sweat Glucose of Patients With Diabetes - The ENGAGE Study

Terminated
NCT00656513Phase 2

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Completed
NCT02754570Not Applicable

The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure

Completed
NCT02613013Not Applicable

Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure

Unknown
NCT01690052Not Applicable

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva

Completed
NCT02935894Not Applicable

Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat

Completed
NCT00602524Not Applicable

Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions

Completed
NCT00618059Not Applicable

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

Completed
NCT00601211Not Applicable

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions

Completed
NCT00601874Not Applicable

Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions

Completed
NCT02982577Phase 4

Effect of Pilocarpine in Patients With Xerostomia

Unknown
NCT02420782Phase 1

First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology

Completed
NCT01036035Phase 1

Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects

Completed
NCT02447315Phase 1

A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22